USD -0.61 as of today(2019-10-16). DNLI EPS (Diluted) explanation, calculation, historical data and more" />DNLI EPS (Diluted) | Denali Therapeutics - GuruFocus.com
Switch to:

Denali Therapeutics EPS (Diluted)

: USD -0.61 (TTM As of Jun. 2019)
View and export this data going back to 2017. Start your Free Trial

Denali Therapeutics's Earnings per Share (Diluted) for the three months ended in Jun. 2019 was USD -0.61. Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Jun. 2019 was USD -0.61.

Denali Therapeutics's EPS (Basic) for the three months ended in Jun. 2019 was USD -0.61. Its EPS (Basic) for the trailing twelve months (TTM) ended in Jun. 2019 was USD -0.58.

Denali Therapeutics's EPS without NRI for the three months ended in Jun. 2019 was USD -0.61. Its EPS without NRI for the trailing twelve months (TTM) ended in Jun. 2019 was USD -0.61.

During the past 3 years, the average EPS without NRIGrowth Rate was 58.80% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EPS without NRI Growth Rate using EPS without NRI data.

During the past 4 years, Denali Therapeutics's highest 3-Year average EPS without NRI Growth Rate was 58.80% per year. The lowest was 58.80% per year. And the median was 58.80% per year.


Denali Therapeutics EPS (Diluted) Historical Data

* All numbers are in millions except for per share data and ratio. All numbers are in their local exchange's currency.

* Premium members only.

Denali Therapeutics Annual Data
Dec15 Dec16 Dec17 Dec18
EPS (Diluted) -5.58 -13.49 -5.89 -0.39

Denali Therapeutics Quarterly Data
Dec15 Dec16 Mar17 Jun17 Sep17 Dec17 Mar18 Jun18 Sep18 Dec18 Mar19 Jun19
EPS (Diluted) Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -0.59 -0.38 0.79 -0.41 -0.61

Competitive Comparison
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap.


Denali Therapeutics EPS (Diluted) Distribution

* The bar in red indicates where Denali Therapeutics's EPS (Diluted) falls into.



Denali Therapeutics EPS (Diluted) Calculation

EPS (Diluted) is a rough measurement of the amount of a company's profit that can be allocated to one share of its stock. Diluted EPS takes into account all of the outstanding dilutive securities that could potentially be exercised (such as stock options and convertible preferred stock) and shows how such an action would impact earnings per share.

Denali Therapeutics's Diluted EPS for the fiscal year that ended in Dec. 2018 is calculated as

Diluted EPS (A: Dec. 2018 ) = (Net Income - Preferred Dividends) / Shares Outstanding (Diluted Average)
=(-36.24-0)/92.622
=-0.39

Denali Therapeutics's Diluted EPS for the quarter that ended in Jun. 2019 is calculated as

Diluted EPS (Q: Jun. 2019 )=(Net Income - Preferred Dividends) / Shares Outstanding (Diluted Average)
=(-58.337-0)/95.495
=-0.61

EPS (Diluted) for the trailing twelve months (TTM) ended in Jun. 2019 was -0.38 (Sep. 2018 ) + 0.79 (Dec. 2018 ) + -0.41 (Mar. 2019 ) + -0.61 (Jun. 2019 ) = USD -0.61

* All numbers are in millions except for per share data and ratio. All numbers are in their local exchange's currency.


Denali Therapeutics  (NAS:DNLI) EPS (Diluted) Explanation

EPS is the single most important variable used by Wall Street in determining the earnings power of a company. But investors need to be aware that Earnings per Share can be easily manipulated by adjusting depreciation and amortization rate or non-recurring items. That's why GuruFocus lists EPS without NRI, which better reflects the company's underlying performance.


Be Aware

Compared with Earnings per share, a company's cash flow is better indicator of the company's earnings power.

If a company's earnings per share is less than cash flow per share over long term, investors need to be cautious and find out why.


Denali Therapeutics EPS (Diluted) Related Terms


Denali Therapeutics EPS (Diluted) Headlines

No Headline

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)